*Disclaimer

PATRYS LIMITED (ASX: PAB)

πŸ”— πŸ“„ πŸ“ˆ

PAB: PAT-DX1 GLP toxicology reports received

PATRYS LIMITED

2023-05-24 09:12:00

PAB: Two new deoxymab patents granted in the USA

PATRYS LIMITED

2023-04-17 09:21:00

PAB: Updated guidance for PAT-DX1 phase 1 clinical study

PATRYS LIMITED

2023-03-31 09:01:00

PAB: New PAT-DX3 data demonstrates synthetic lethality

PATRYS LIMITED

2023-03-14 09:00:00

PAB: Patrys Receives R&D Tax Incentive Refund

PATRYS LIMITED

2023-01-30 09:51:00